Companies / Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc.

Nasdaq: ARCTCIK 1768224SAN DIEGO, CA

Financials · FY2025

Revenue$82.03M
Net income$-65.78M
Total debt$15.00M
Cash$191.48M
Diluted EPS$-2.40
Shares outstanding28.4M

Ownership

28.4M shares outstanding · as of Aug 4, 2026
88.1%Institutions
Ownership
Institutions88.14%25,050,844
Public float11.86%3,372,225

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
Mulroy DennisChief Financial Officer

Institutional holders 125

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Two Sigma Investments, LP
13F manager
AddCommon stock$4.13M+535K
+97.88%
1,081,784
3.81% of shares
low
Q4 2025
as of
Bank of America Corp /De
13F manager
TrimCommon stock$-3.59M-586K
-94.50%
34,088
0.12% of shares
low
Q1 2024
as of
Barclays PLC
13F manager
TrimCommon stock$-1.65M-49K
-57.70%
35,744
0.13% of shares
low
Q1 2026
as of
Millennium Management LLC
13F manager
AddCommon stock$1.34M+174K
+57.02%
478,557
1.68% of shares
low
Q1 2026
as of
D. E. Shaw & Co., Inc.
13F manager
AddCommon stock$1.19M+154K
+157.64%
252,034
0.89% of shares
low
Q1 2026
as of
AQR Capital Management, LLC
13F manager
AddCommon stock$910.0K+118K
+271.58%
161,278
0.57% of shares
low
Q4 2023
as of
Barclays PLC
13F manager
TrimCommon stock$-881.5K-28K
-24.86%
84,509
0.30% of shares
low
Q2 2025
as of
Barclays PLC
13F manager
AddCommon stock$614.9K+47K
+99.45%
94,793
0.33% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A0
Federated Hermes IncPassive13G/A
Balyasny Asset Management L.P.Passive13G/A0
ARK Investment Management LLCPassive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ARCT03969T109